Provided are compounds, pharmaceutical acceptable salts, polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising the compounds may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup or injection, and may be used for the treatment of neurologic diseases, such as depression, Alzheimer's disease, multiple sclerosis, Batten disease, Parkinson's disease and restless legs syndrome.
提供的是化合物、药用可接受的盐、多型体、溶剂络合物、对映体、立体异构体和
水合物。包含这些化合物的药物组合物可以制备成口服、颊下、直肠、局部、经皮、经粘膜、静脉内、全身注射、糖浆或注射剂,并可用于治疗神经系统疾病,如抑郁症、阿尔茨海默病、多发性硬化症、巴顿病、帕
金森病和不安腿综合症。